← RxSight, Inc.
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $14.7m |
$22.6m
+53.92%
|
$49.0m
+116.90%
|
$89.1m
+81.77%
|
$139.9m
+57.09%
|
$134.5m
-3.89%
|
$127.6m
-5.13%
|
|
| Cost of Revenue | $13.0m |
$18.1m
+39.34%
|
$27.7m
+53.11%
|
$35.3m
+27.59%
|
$41.0m
+16.06%
|
$31.5m
-23.21%
|
$28.7m
-8.78%
|
|
| Net Interest Income | — | — | ($3.4m) |
$3.3m
+195.25%
|
$9.5m
+189.44%
|
$9.3m
-1.48%
|
$8.3m
-11.16%
|
|
| Gross Profit | $1.7m |
$4.5m
+164.93%
|
$21.3m
+372.17%
|
$53.8m
+152.09%
|
$98.9m
+84.03%
|
$103.0m
+4.11%
|
$98.9m
-4.01%
|
|
| Research And Development | $21.9m | $24.5m | $26.0m | $29.1m | $34.4m | $38.5m | $36.7m | |
| Operating Expenses | $37.1m | $57.3m | $84.6m | $103.8m | $135.8m | $151.2m | $154.0m | |
| Operating Income (Loss) | ($35.4m) |
($52.8m)
-49.07%
|
($63.3m)
-19.95%
|
($50.1m)
+20.90%
|
($36.9m)
+26.41%
|
($48.2m)
-30.75%
|
($55.1m)
-14.36%
|
|
| Interest Expense | $510k | $3.7m | $4.9m | $3.3m | $21k | $19k | $14k | |
| Interest Income | — | $54k | $1.5m | $6.6m | $9.5m | $9.3m | $8.3m | |
| Net Non Operating Interest Income Expense | — | — | ($3.4m) | $3.3m | $9.5m | $9.3m | $8.3m | |
| Interest and Other Income | — | $54k | $1.5m | $6.6m | $9.5m | $9.3m | — | |
| Other Income Expense | — | $7.7m | — | ($1.8m) | — | — | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $27.6m | ($48.7m) | ($66.8m) | ($48.6m) | ($27.4m) | ($38.9m) | ($46.8m) | |
| Pre-Tax Income | $27.6m | ($48.7m) | ($66.7m) | ($48.6m) | ($27.4m) | ($38.9m) | ($46.8m) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $27.6m | ($48.7m) | ($66.7m) | ($48.6m) | ($27.4m) | ($38.9m) | ($46.8m) | |
| Current Income Tax Expense (Benefit) | $57k | $8k | $9k | $20k | $50k | $66k | $110k | |
| Net Income From Continuing And Discontinued Operation | $27.6m | ($48.7m) | ($66.8m) | ($48.6m) | ($27.5m) | ($38.9m) | ($46.9m) | |
| Earnings Per Share, Basic | $0.91 | ($3.57) | ($2.41) | ($1.41) | ($0.71) | ($0.95) | ($1.14) | |
| Earnings Per Share, Diluted | $0.15 | ($3.57) | ($2.41) | ($1.41) | ($0.71) | ($0.95) | ($1.14) | |
| Weighted Average Number of Shares Outstanding, Basic | 3.7m | 13.6m | 27.7m | 34.5m | 38.9m | 40.9m | 41.2m | |
| Basic Average Shares | 3.7m | 13.6m | $27.7m | $34.5m | $38.9m | $40.9m | $41.2m | |
| Diluted Average Shares | 3.7m | 13.6m | $27.7m | $34.5m | $38.9m | $40.9m | $41.2m | |
| Weighted Average Number of Shares Outstanding, Diluted | 5.5m | 13.6m | 27.7m | 34.5m | 38.9m | 40.9m | 41.2m | |
| Additional Financial Items | ||||||||
| Diluted EPS | $0.91 | ($3.57) | ($2.41) | ($1.41) | ($0.71) | ($0.95) | ($1.14) | |
| Diluted NI Availto Com Stockholders | $27.6m | ($48.7m) | ($66.8m) | ($48.6m) | ($27.5m) | ($38.9m) | ($46.9m) | |
| Normalized EBITDA | — | — | ($57.8m) | ($39.4m) | ($23.8m) | ($35.6m) | ($43.3m) | |
| Normalized Income | — | — | ($66.8m) | ($46.8m) | ($27.5m) | ($38.9m) | ($46.9m) | |
| Reconciled Depreciation | — | — | $4.0m | $4.1m | $3.6m | $3.3m | $3.5m | |
| Selling General And Administration | $15.2m | $32.8m | $58.7m | $74.8m | $101.4m | $112.7m | — | |
| Special Income Charges | — | — | $0 | ($1.8m) | $0 | $0 | $0 | |
| Tax Effect Of Unusual Items | — | — | $0 | $0 | $0 | $0 | $0 | |
| Tax Provision | $57k | $8k | $9k | $20k | $50k | $66k | $110k | |
| Tax Rate For Calcs | — | — | $0 | $0 | $0 | $0 | $0 | |
| Cost, Depreciation and Amortization | $3.9m | $4.0m | $3.9m | $4.1m | $3.6m | $3.3m | — | |
| Total Unusual Items | — | — | $0 | ($1.8m) | $0 | $0 | $0 | |
| Total Expenses | — | — | $112.3m | $139.2m | $176.8m | $182.7m | $182.7m |